DPP4 and Hypoglycemia: Considering the fact that DPP4 activity inhibitors does not cause hypoglycemia, our findings in this study showed that DPP4 inhibitors might also hold promise for the treatment of impaired cognitive function in non-diabetic population but further controlled studies with specific clinical endpoints are still needed to assess their effects in this population.